Authors: Nordenstrom, A Wedell, A Hagenfeldt, L Marcus, C Larsson, A

Citation: A. Nordenstrom et al., Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants, PEDIATRICS, 108(4), 2001, pp. NIL_66-NIL_73

Authors: Nordenstrom, A Marcus, C Axelson, M Wedell, A Ritzen, M

Citation: A. Nordenstrom et al., Defective 11 beta-HSD reductase activity in a patient with congenital adrenal hyperplasia, J CLIN END, 86(3), 2001, pp. 1426-1427

Authors: Nordenstrom, A Thilen, A Hagenfeldt, L Larsson, A Wedell, A

Citation: A. Nordenstrom et al., Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency, J CLIN END, 84(5), 1999, pp. 1505-1509

Authors: Nordenstrom, A Marcus, C Axelson, M Wedell, A Ritzen, EM

Citation: A. Nordenstrom et al., Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11 beta-hydroxysteroid dehydrogenase reductase activity, J CLIN END, 84(4), 1999, pp. 1210-1213